Trial intelligence / Profile preview

Metformin versus placebo in newly diagnosed type 1 diabetes mellitus

2008-005797-12Phase 3Active

Sponsor
Policlinico di Bari
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in diabetes mellitus type 1 (T1D) comparing Metformin adjunct arm with Placebo adjunct arm (2 arms). Primary endpoint: Preservation of residual beta-cell function. Started Sep 2008; status: active.

02

Drugs

metformin
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2008-005797-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005797-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call